Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 34 of 45 for:    thalidomide myeloma | Recruiting, Not yet recruiting, Available Studies

Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03715478
Recruitment Status : Recruiting
First Posted : October 23, 2018
Last Update Posted : July 29, 2019
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Myeloma Canada Research Network

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 1, 2023
  Estimated Study Completion Date : December 31, 2024